Skip to main content
. Author manuscript; available in PMC: 2020 Mar 24.
Published in final edited form as: Bone Marrow Transplant. 2019 Sep 24;55(2):409–418. doi: 10.1038/s41409-019-0694-y

Table 2.

Effect of HLA match on transplant outcomes (N=304)*

Clinical endpoint HLA Match N Events Hazard ratio 95% CI p
OS 11/12 166 50
10/12 65 30 1.68 1.07 -2.64 0.02
12/12 73 32 1.61 1.03 -2.51 0.04
EFS 11/12 166 64
10/12 65 33 1.47 0.96-2.24 0.07
12/12 73 40 1.66 1.12-2.47 0.01
CIR 11/12 166 30
10/12 65 14 1.25 0.66-2.35 0.50
12/12 73 24 2.02 1.18-3.47 0.01
NRM 11/12 166 34
10/12 65 19 1.48 0.84-2.59 0.17
12/12 73 16 1.09 0.61-1.96 0.76
Acute GvHD II-IV 11/12 165 66
10/12 65 35 1.43 0.95-2.15 0.09
12/12 72 27 0.92 0.59-1.44 0.72
Acute GvHD III-IV 11/12 165 22
10/12 65 14 1.57 0.79-3.13 0.20
12/12 73 11 1.14 0.55-2.36 0.73
Chronic GvHD 11/12 164 119
10/12 65 48 1.19 0.84-1.69 0.32
12/12 73 47 0.84 0.60-1.19 0.33
*

All models are multivariable and adjusted for age (<58 vs. ≥58) and disease risk (high, intermediate, low/non-malignant). Patients with incomplete clinical data or with disease risk of other were excluded.